JOHNSON & JOHNSON·4

Aug 25, 4:07 PM ET

McEvoy Ashley 4

4 · JOHNSON & JOHNSON · Filed Aug 25, 2023

Insider Transaction Report

Form 4
Period: 2023-08-23
McEvoy Ashley
EVP, WW Chair, Medical Devices
Transactions
  • Disposition to Issuer

    Common Stock

    2023-08-232,78752,037.955 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    2,806
  • Common Stock

    (indirect: By ESOP)
    300
Footnotes (4)
  • [F1]The Compensation & Benefits Committee of the Board of Directors of Johnson & Johnson approved the disposition of these shares of Johnson & Johnson common stock.
  • [F2]On August 23, 2023, Johnson & Johnson commenced a registered exchange offer to holders of shares of Johnson & Johnson common stock to exchange Johnson & Johnson common stock for Kenvue Inc. (Kenvue) common stock. The final exchange ratio was 8.0324 shares of Kenvue common stock per share of Johnson & Johnson common stock accepted in the exchange offer.
  • [F3]Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (7/31/2023).
  • [F4]Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (7/31/2023).

Documents

1 file
  • 4
    doc4.xmlPrimary